Literature DB >> 33981057

How COVID broke the evidence pipeline.

Helen Pearson.   

Abstract

Entities:  

Keywords:  Health care; Medical research; SARS-CoV-2; Virology

Mesh：

Substances：

Year:  2021        PMID： 33981057     DOI： 10.1038/d41586-021-01246-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

Review 1.  Avoidable waste in the production and reporting of research evidence.

Authors:  Iain Chalmers; Paul Glasziou
Journal:  Lancet       Date:  2009-06-12       Impact factor: 79.321

2.  Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Authors: 
Journal:  Lancet       Date:  2021-05-01       Impact factor: 79.321
  2 in total
  19 in total

1.  Decision makers need constantly updated evidence synthesis.

Authors:  Julian Elliott; Rebecca Lawrence; Jan C Minx; Olufemi T Oladapo; Philippe Ravaud; Britta Tendal Jeppesen; James Thomas; Tari Turner; Per Olav Vandvik; Jeremy M Grimshaw
Journal:  Nature       Date:  2021-12       Impact factor: 49.962

2.  Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.

Authors:  Stephen R Hanney; Sharon E Straus; Bev J Holmes
Journal:  Health Res Policy Syst       Date:  2022-09-10

3.  Invited Discussion on: "Nanofat Cell-Mediated Anti-Aging Therapy: Evidence-Based Analysis of Efficacy and an Update of Stem Cell Facelift" by Bishara Atiyeh, Fadi Ghieh, Ahmad Oneisi.

Authors:  Alexis Verpaele; Patrick Tonnard; Mohammad Ghiasloo
Journal:  Aesthetic Plast Surg       Date:  2021-09-16       Impact factor: 2.326

4.  Has anything changed in Evidence-Based Medicine?

Authors:  George D Chloros; Apostolos D Prodromidis; Peter V Giannoudis
Journal:  Injury       Date:  2022-04-20       Impact factor: 2.687

5.  Epidemiological models and COVID-19: a comparative view.

Authors:  Valeriano Iranzo; Saúl Pérez-González
Journal:  Hist Philos Life Sci       Date:  2021-08-25       Impact factor: 1.205

6.  Editorial 2021: Changes to the guidelines for authors for publishing in Archives of Virology.

Authors:  Tim Skern
Journal:  Arch Virol       Date:  2022-01-29       Impact factor: 2.574

7.  Did our pharmacological strategy for COVID-19 fail?

Authors:  Jennifer H Martin; Michelle Baddeley; Richard Head
Journal:  Pharmacol Res Perspect       Date:  2021-12

8.  Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results.

Authors:  Ariel Izcovich; Sasha Peiris; Martín Ragusa; Fernando Tortosa; Gabriel Rada; Sylvain Aldighieri; Ludovic Reveiz
Journal:  J Clin Epidemiol       Date:  2021-12-18       Impact factor: 6.437

Review 9.  Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.

Authors:  Giuliano Ramadori
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 10.  The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes.

Authors:  Alexandra Bouariu; Nicolae Gică; Anca Marina Ciobanu; Ana Maria Scutelnicu; Mihaela Roxana Popescu; Anca Maria Panaitescu
Journal:  Healthcare (Basel)       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.